BioAmber reports net loss of $9 million for third quarter 2013

In Minnesota, BioAmber announced a net loss of $9.0 million, or $0.48 per share, for the three months ended September 30, 2013, compared to $11.6 million, or $1.12 per share, for the three months ended September 30, 2012.  Highlights including achieving the final development milestone for the yeast licensed exclusively from Cargill, sales of 866,000 of bio-succinic acid in Q3 2013.  The sales generated a gross margin of 24%.  BioAmber stated that it had reduced its monthly operating cash burn to $1.68M in Q3 2013, 17% lower than Q2 2013.